The contribution of CYP3a4 and CYP3A5 on the metabolism of sildenafil, vardenafil, and udenafil.

被引：0
|
作者：
Ku, H. [1 ]
Bae, S. [1 ]
Seo, K. [1 ]
Ahn, H. [1 ]
Bae, S. [1 ]
Shon, J. [1 ]
Liu, K. [1 ]
Shin, J. [1 ]
机构：
[1] Inje Univ, Coll Med, PharmacoGenom Res Ctr, Dept Pharmacol, Pusan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [11] In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans
    Hirota, N
    Ito, K
    Iwatsubo, T
    Green, CE
    Tyson, CA
    Shimada, N
    Suzuki, H
    Sugiyama, Y
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2001, 22 (02) : 53 - 71
  • [12] Statin regulation of CYP3A4 and CYP3A5 expression
    Vieira Willrich, Maria Alice
    Hirata, Mario Hiroyuki
    Crespo Hirata, Rosario Dominguez
    PHARMACOGENOMICS, 2009, 10 (06) : 1017 - 1024
  • [13] Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
    A. B. Sanchez Spitman
    D. J. A. R. Moes
    H. Gelderblom
    V. O. Dezentje
    J.J. Swen
    H. J. Guchelaar
    European Journal of Clinical Pharmacology, 2017, 73 : 1589 - 1598
  • [14] Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
    Spitman, A. B. Sanchez
    Moes, D. J. A. R.
    Gelderblom, H.
    Dezentje, V. O.
    Swen, J. J.
    Guchelaar, H. J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (12) : 1589 - 1598
  • [15] Investigation of the structural basis for the differential metabolism of glucocorticoids by CYP3A4 and CYP3A5 enzymes
    Shahrokh, Kiumars
    Yost, Garold S.
    Cheatham, Thomas E., III
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [16] Metabolism of Quetiapine by CYP3A4 and CYP3A5 in Presence or Absence of Cytochrome B5
    Bakken, Gry Vibeke
    Rudberg, Ida
    Christensen, Hege
    Molden, Espen
    Refsum, Helge
    Hermann, Monica
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (02) : 254 - 258
  • [17] Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes
    Leel, Jin Sol
    Cheong, Hyun Sub
    Kim, Lyoung Hyo
    Kixn, Ji On
    Seo, Doo Won
    Kim, Young Hoon
    Chung, Myeon Woo
    Han, Soon Young
    Shin, Hyoung Doo
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2013, 17 (06): : 479 - 484
  • [18] NEW TOOLS TO DIFFERENTIATE CYP3A4 AND CYP3A5 ACTIVITY
    Li, Xiaohai
    Kamenecka, Theodore M.
    Jeso, Valer
    Micalizio, Glen
    Heyward, Scott
    Walker, Gregory S.
    Cameron, Michael D.
    DRUG METABOLISM REVIEWS, 2015, 47 : 70 - 70
  • [19] Differential inhibition of CYP3A4 and CYP3A5 by verapamil.
    Wang, Y
    Jones, DR
    Hall, SD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P16 - P16
  • [20] GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES.
    Quinney, S. K.
    Schwartz, J. B.
    Hall, S. D.
    Gorski, J. C.
    Li, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S49 - S49
12345